Abstract

Primary progressive aphasia (PPA) is a clinical dementia syndrome with early symptoms of language dysfunction. Postmortem findings are varied and include Alzheimer disease and frontotemporal lobar degeneration (FTLD), both tauopathies and TAR DNA binding protein (TDP-43) proteinopathies. Clinical-pathological correlations in PPA are complex but the presence in the clinical profile of agrammatism has a high association with tauopathy. Grammatical competence is difficult to assess in the clinical setting with available methods. This article describes the Northwestern Anagram Test (NAT), a new clinical measure of sentence production. A total of 16 patients with PPA and their controls assembled single printed words to create sentences describing pictures. Northwestern Anagram Test performance was significantly correlated with a measure of sentence production and with aphasia severity but not with measures of naming, single word comprehension, object recognition, or motor speech. The NAT can be used to assess syntax competence when patients cannot be tested with measures that require intact speech production.

Original languageEnglish (US)
Pages (from-to)408-416
Number of pages9
JournalAmerican Journal of Alzheimer's Disease and other Dementias
Volume24
Issue number5
DOIs
StatePublished - Jan 1 2009

Fingerprint

Primary Progressive Aphasia
Tauopathies
Mental Competency
TDP-43 Proteinopathies
Frontotemporal Lobar Degeneration
Broca Aphasia
Aphasia
DNA-Binding Proteins
Dementia
Alzheimer Disease
Language

Keywords

  • Frontotemporal dementia
  • Grammar
  • Speech
  • Syntax

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

@article{194ab253033541d4b7289b188714d83e,
title = "The northwestern anagram test: Measuring sentence production in primary progressive aphasia",
abstract = "Primary progressive aphasia (PPA) is a clinical dementia syndrome with early symptoms of language dysfunction. Postmortem findings are varied and include Alzheimer disease and frontotemporal lobar degeneration (FTLD), both tauopathies and TAR DNA binding protein (TDP-43) proteinopathies. Clinical-pathological correlations in PPA are complex but the presence in the clinical profile of agrammatism has a high association with tauopathy. Grammatical competence is difficult to assess in the clinical setting with available methods. This article describes the Northwestern Anagram Test (NAT), a new clinical measure of sentence production. A total of 16 patients with PPA and their controls assembled single printed words to create sentences describing pictures. Northwestern Anagram Test performance was significantly correlated with a measure of sentence production and with aphasia severity but not with measures of naming, single word comprehension, object recognition, or motor speech. The NAT can be used to assess syntax competence when patients cannot be tested with measures that require intact speech production.",
keywords = "Frontotemporal dementia, Grammar, Speech, Syntax",
author = "Sandra Weintraub and Mesulam, {M. Marsel} and Christina Wieneke and Alfred Rademaker and Rogalski, {Emily J.} and Thompson, {Cynthia K.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1177/1533317509343104",
language = "English (US)",
volume = "24",
pages = "408--416",
journal = "American Journal of Alzheimer's Disease and other Dementias",
issn = "1533-3175",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - The northwestern anagram test

T2 - Measuring sentence production in primary progressive aphasia

AU - Weintraub, Sandra

AU - Mesulam, M. Marsel

AU - Wieneke, Christina

AU - Rademaker, Alfred

AU - Rogalski, Emily J.

AU - Thompson, Cynthia K.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Primary progressive aphasia (PPA) is a clinical dementia syndrome with early symptoms of language dysfunction. Postmortem findings are varied and include Alzheimer disease and frontotemporal lobar degeneration (FTLD), both tauopathies and TAR DNA binding protein (TDP-43) proteinopathies. Clinical-pathological correlations in PPA are complex but the presence in the clinical profile of agrammatism has a high association with tauopathy. Grammatical competence is difficult to assess in the clinical setting with available methods. This article describes the Northwestern Anagram Test (NAT), a new clinical measure of sentence production. A total of 16 patients with PPA and their controls assembled single printed words to create sentences describing pictures. Northwestern Anagram Test performance was significantly correlated with a measure of sentence production and with aphasia severity but not with measures of naming, single word comprehension, object recognition, or motor speech. The NAT can be used to assess syntax competence when patients cannot be tested with measures that require intact speech production.

AB - Primary progressive aphasia (PPA) is a clinical dementia syndrome with early symptoms of language dysfunction. Postmortem findings are varied and include Alzheimer disease and frontotemporal lobar degeneration (FTLD), both tauopathies and TAR DNA binding protein (TDP-43) proteinopathies. Clinical-pathological correlations in PPA are complex but the presence in the clinical profile of agrammatism has a high association with tauopathy. Grammatical competence is difficult to assess in the clinical setting with available methods. This article describes the Northwestern Anagram Test (NAT), a new clinical measure of sentence production. A total of 16 patients with PPA and their controls assembled single printed words to create sentences describing pictures. Northwestern Anagram Test performance was significantly correlated with a measure of sentence production and with aphasia severity but not with measures of naming, single word comprehension, object recognition, or motor speech. The NAT can be used to assess syntax competence when patients cannot be tested with measures that require intact speech production.

KW - Frontotemporal dementia

KW - Grammar

KW - Speech

KW - Syntax

UR - http://www.scopus.com/inward/record.url?scp=70349675754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349675754&partnerID=8YFLogxK

U2 - 10.1177/1533317509343104

DO - 10.1177/1533317509343104

M3 - Article

VL - 24

SP - 408

EP - 416

JO - American Journal of Alzheimer's Disease and other Dementias

JF - American Journal of Alzheimer's Disease and other Dementias

SN - 1533-3175

IS - 5

ER -